Retatrutide (LY3437943)
Investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, widely studied in preclinical and clinical metabolic models for energy expenditure and lipid oxidation.
Reference molecular weights for LC-MS verification, CAS registry identifiers, shorthand vendor aliases, standard volumetric reconstitution math, and top-scored domestic US & EU suppliers.
Investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, widely studied in preclinical and clinical metabolic models for energy expenditure and lipid oxidation.
Dual incretin receptor agonist with imbalanced affinity favoring GIP over GLP-1 signaling, serving as a primary reference standard in glycemic and adipocyte signaling studies.
Foundational single-receptor GLP-1 mimetic featuring C18 diacid albumin-binding acylation and Aib8 substitution for DPP-4 enzymatic resistance.
Synthetic 15-amino-acid sequence investigated extensively in rodent tendon, ligament, microvascular angiogenesis (VEGFR2/eNOS), and gastrointestinal mucosal models.
Actin-monomer binding peptide studied for dermal wound closure, cytoskeletal cell migration, and cardiac/corneal tissue remodeling; frequently paired with BPC-157 in dual-peptide assays.
Naturally occurring plasma tripeptide-copper complex studied for extracellular matrix remodeling, collagen I/III gene modulation, and antioxidant SOD upregulation.
Short-acting GHRH receptor agonist engineered with four amino-acid substitutions (Ala2, Gln8, Ala15, Leu27) to prevent rapid DPP-4 cleavage while preserving pulsatile somatotroph signaling.
Selective pentapeptide ghrelin-receptor (GHS-R1a) agonist characterized in endocrine research for stimulating GH release without off-target ACTH, cortisol, or prolactin elevation.
Full-length 44-residue stabilized GHRH analogue bearing an N-terminal hexenoyl moiety, studied extensively for visceral adipose tissue lipolysis and pulsatile IGF-1 regulation.
Pineal-derived synthetic tetrapeptide researched in telomerase hTERT activation, melatonin rhythm restoration, and replicative senescence cell-culture assays.
Mitochondrial-encoded 16-amino-acid peptide regulating the folate-AICAR-AMPK metabolic axis and stress-induced nuclear gene translocation in skeletal muscle models.
Cardiolipin-binding inner mitochondrial membrane tetrapeptide studied for electron transport chain stabilization, ATP restoration, and mitochondrial ROS attenuation.
Central cellular electron carrier and obligatory cosubstrate for sirtuin deacetylases (SIRT1–7) and PARP DNA-repair enzymes in aging research.
Non-hormonal ACTH(4-10) heptapeptide analogue studied for hippocampal BDNF/TrkB mRNA upregulation, cerebral ischemia neuroprotection, and melanocortin modulation.
Synthetic analogue of endogenous immunomodulatory tetrapeptide tuftsin extended with Pro-Gly-Pro, studied for allosteric GABAA modulation and enkephalinase inhibition.
Small-molecule pan-estrogen-related receptor (ERRα/β/γ) agonist developed to activate acute aerobic exercise transcriptional programs and mitochondrial fatty-acid oxidation in murine models.
Minimal C-terminal tripeptide of alpha-melanocyte-stimulating hormone retaining NF-κB anti-inflammatory suppression without MC1R pigmentary activation.
28-amino-acid acetylated polypeptide investigated for Toll-like receptor (TLR2/9) dendritic signaling, T-cell maturation, and NK-cell cytotoxicity modulation.
De-amidated cyclic heptapeptide metabolite of Melanotan II acting centrally at hypothalamic MC4R/MC3R receptors.
C-terminal lipolytic domain of human growth hormone containing a Cys182–Cys189 disulfide loop, researched for beta-3 adrenergic lipolysis without IGF-1 elevation.